Copyright
©The Author(s) 2017.
World J Gastroenterol. Feb 28, 2017; 23(8): 1338-1344
Published online Feb 28, 2017. doi: 10.3748/wjg.v23.i8.1338
Published online Feb 28, 2017. doi: 10.3748/wjg.v23.i8.1338
Table 2 TGR5 expression in squamous mucosa, Barrett’s esophagus, low-grade dysplasia, high-grade dysplasia and esophageal adenocarcinoma n (%)
| Negative | Weak | Moderate | Strong | ||
| Squamous mucosa, n = 18 | 13 (72) | 5 (28) | 0 | 0 | |
| Barrett’s esophagus, n = 15 | 1 (6.7) | 12 (80) | 2 (13.3) | 0 | P < 0.001, compared with squamous mucosa |
| Low grade dysplasia, n = 8 | 0 | 5 (62.5) | 2 (25) | 1 (12.5) | P > 0.05, compared with BE |
| High grade dysplasia, n = 9 | 1 (11.1) | 0 | 2 (22.2) | 6 (66.7) | P < 0.001, compared with BE |
| P < 0.05, compared with low grade dysplasia | |||||
| EA, n = 16 | 0 | 0 | 7 (43.7) | 9 (56.3) | P < 0.001, compared with BE |
| P < 0.01, compared with low grade dysplasia |
- Citation: Marketkar S, Li D, Yang D, Cao W. TGR5 expression in benign, preneoplastic and neoplastic lesions of Barrett’s esophagus: Case series and findings. World J Gastroenterol 2017; 23(8): 1338-1344
- URL: https://www.wjgnet.com/1007-9327/full/v23/i8/1338.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i8.1338